Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

ClinicalTrials.gov ID: NCT01442194

Public ClinicalTrials.gov record NCT01442194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term, Prospective,Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease-modifying therapy, is to further explore the incidence of selected safety- related outcomes and to further monitor the overall safety profile of fingolimod under conditions of routine medical practice.

Study identification

NCT ID
NCT01442194
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
3,076 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2011 (Actual)
Primary completion
Jul 10, 2020 (Actual)
Completion
Jul 10, 2020 (Actual)
Last update posted
Jan 14, 2022

2011 – 2020

United States locations

U.S. sites
208
U.S. states
42
U.S. cities
184
Facility City State ZIP Site status
Novartis Investigative Site Birmingham Alabama 35209 —
Novartis Investigative Site Birmingham Alabama 35233-0271 —
Novartis Investigative Site Birmingham Alabama 35235 —
Novartis Investigative Site Cullman Alabama 35058 —
Novartis Investigative Site Mobile Alabama 36617 —
Novartis Investigative Site Phoenix Arizona 85013 —
Novartis Investigative Site Sottsdale Arizona 85258 —
Novartis Investigative Site Tucson Arizona 85718 —
Novartis Investigative Site Bakersfield California 93311 —
Novartis Investigative Site Banning California 92220 —
Novartis Investigative Site Burbank California 91505 —
Novartis Investigative Site Fresno California 93710 —
Novartis Investigative Site Fullerton California 92835 —
Novartis Investigative Site Huntington Beach California 92649 —
Novartis Investigative Site Irvine California 92618 —
Novartis Investigative Site Loma Linda California 92354 —
Novartis Investigative Site Los Angeles California 90073 —
Novartis Investigative Site Newport Beach California 92660 —
Novartis Investigative Site Oceanside California 92056 —
Novartis Investigative Site Placentia California 92870 —
Novartis Investigative Site Pomona California 91767 —
Novartis Investigative Site Redding California 96001 —
Novartis Investigative Site Santa Monica California 90404 —
Novartis Investigative Site Temecula California 92591 —
Novartis Investigative Site Aurora Colorado 80045 —
Novartis Investigative Site Basalt Colorado 81621 —
Novartis Investigative Site Colorado Springs Colorado 80907 —
Novartis Investigative Site Denver Colorado 80210 —
Novartis Investigative Site Fort Collins Colorado 80524 —
Novartis Investigative Site Louisville Colorado 80027 —
Novartis Investigative Site Parker Colorado 80138 —
Novartis Investigative Site Fairfield Connecticut 06824 —
Novartis Investigative Site Hartford Connecticut 6112 —
Novartis Investigative Site Waterbury Connecticut 06708 —
Novartis Investigative Site Dover Delaware 19901 —
Novartis Investigative Site Newark Delaware 19713 —
Novartis Investigative Site Washington D.C. District of Columbia 20007 —
Novartis Investigative Site Washington D.C. District of Columbia 20037 —
Novartis Investigative Site Bradenton Florida 34205 —
Novartis Investigative Site Clermont Florida 34711 —
Novartis Investigative Site Delray Beach Florida 33445 —
Novartis Investigative Site Doral Florida 33136 —
Novartis Investigative Site Hollywood Florida 33021 —
Novartis Investigative Site Jupiter Florida 33458 —
Novartis Investigative Site Maitland Florida 32751 —
Novartis Investigative Site Miami Florida 33032 —
Novartis Investigative Site Miami Florida 33144 —
Novartis Investigative Site Miami Florida 33155 —
Novartis Investigative Site Naples Florida 34102 —
Novartis Investigative Site Orlando Florida 32806 —
Novartis Investigative Site Ormond Beach Florida 32174 —
Novartis Investigative Site Panama City Florida 32405 —
Novartis Investigative Site Port Charlotte Florida 33952 —
Novartis Investigative Site Sarasota Florida 34233 —
Novartis Investigative Site Wellington Florida 33414 —
Novartis Investigative Site West Palm Beach Florida 33407 —
Novartis Investigative Site Weston Florida 33331 —
Novartis Investigative Site Atlanta Georgia 30309 —
Novartis Investigative Site Atlanta Georgia 30327 —
Novartis Investigative Site Augusta Georgia 30912 —
Novartis Investigative Site Macon Georgia 31210 —
Novartis Investigative Site Suwanee Georgia 30024 —
Novartis Investigative Site Arlington Heights Illinois 60004 —
Novartis Investigative Site Carbondale Illinois 62901 —
Novartis Investigative Site Flossmoor Illinois 60422 —
Novartis Investigative Site Marywood Illinois 60153 —
Novartis Investigative Site Peoria Illinois 61637 —
Novartis Investigative Site Anderson Indiana 46011 —
Novartis Investigative Site Indianapolis Indiana 46227 —
Novartis Investigative Site Indianapolis Indiana 46256 —
Novartis Investigative Site Lafayette Indiana 47905 —
Novartis Investigative Site Merrillville Indiana 46410 —
Novartis Investigative Site Des Moines Iowa 50314-2611 —
Novartis Investigative Site Kansas City Kansas 66160 —
Novartis Investigative Site Lenexa Kansas 66212 —
Novartis Investigative Site Overland Park Kansas 66210 —
Novartis Investigative Site Topeka Kansas 66606 —
Novartis Investigative Site Lexington Kentucky 40503 —
Novartis Investigative Site Lexington Kentucky 40513 —
Novartis Investigative Site Louisville Kentucky 40202 —
Novartis Investigative Site Hammond Louisiana 70403 —
Novartis Investigative Site Auburn Maine 04210 —
Novartis Investigative Site Bangor Maine 04401 —
Novartis Investigative Site Baltimore Maryland 21201 —
Novartis Investigative Site Baltimore Maryland 21209 —
Novartis Investigative Site Baltimore Maryland 21212 —
Novartis Investigative Site Bethesda Maryland 20814 —
Novartis Investigative Site Charlotte Hall Maryland 20622 —
Novartis Investigative Site Hagerstown Maryland 21741 —
Novartis Investigative Site Lutherville Maryland 21093 —
Novartis Investigative Site Waldorf Maryland 20603 —
Novartis Investigative Site Boston Massachusetts 02135 —
Novartis Investigative Site Boston Massachusetts 02215 —
Novartis Investigative Site Foxborough Massachusetts 02035 —
Novartis Investigative Site Springfield Massachusetts 01104 —
Novartis Investigative Site Wellesley Massachusetts 02481 —
Novartis Investigative Site Worcester Massachusetts 01608 —
Novartis Investigative Site Caro Michigan 48723 —
Novartis Investigative Site Detroit Michigan 48201 —
Novartis Investigative Site Jackson Michigan 49201 —
Novartis Investigative Site Owosso Michigan 48867 —
Novartis Investigative Site Rochester Hills Michigan 48301 —
Novartis Investigative Site Southfield Michigan 48034 —
Novartis Investigative Site Traverse City Michigan 49684-2340 —
Novartis Investigative Site Edina Minnesota 55435 —
Novartis Investigative Site Golden Valley Minnesota 55422 —
Novartis Investigative Site City of Saint Peters Missouri 63303 —
Novartis Investigative Site Springfield Missouri 65807 —
Novartis Investigative Site St Louis Missouri 63104 —
Novartis Investigative Site St Louis Missouri 63128 —
Novartis Investigative Site Great Falls Montana 59405 —
Novartis Investigative Site Hastings Nebraska 68901 —
Novartis Investigative Site Omaha Nebraska 68198-2045 —
Novartis Investigative Site Las Vegas Nevada 89106 —
Novartis Investigative Site Lebanon New Hampshire 03756 —
Novartis Investigative Site Fair Lawn New Jersey 07410 —
Novartis Investigative Site Livingston New Jersey 07039 —
Novartis Investigative Site Somerset New Jersey 08873 —
Novartis Investigative Site West Long Branch New Jersey 07764 —
Novartis Investigative Site Albany New York 12208 —
Novartis Investigative Site Amherst New York 14226 —
Novartis Investigative Site Brooklyn New York 11220 —
Novartis Investigative Site Cedarhurst New York 11516 —
Novartis Investigative Site Johnson City New York 13790 —
Novartis Investigative Site Kingston New York 12401 —
Novartis Investigative Site Lake Success New York 11042 —
Novartis Investigative Site New York New York 10003 —
Novartis Investigative Site Patchogue New York 11772 —
Novartis Investigative Site Plainview New York 11803 —
Novartis Investigative Site Poughkeepsie New York 12601 —
Novartis Investigative Site Staten Island New York 10306 —
Novartis Investigative Site Syracuse New York 13210 —
Novartis Investigative Site The Bronx New York 10467 —
Novartis Investigative Site Asheville North Carolina 28805 —
Novartis Investigative Site Asheville North Carolina 28806 —
Novartis Investigative Site Chapel Hill North Carolina 27599-9500 —
Novartis Investigative Site Charlotte North Carolina 28202 —
Novartis Investigative Site Charlotte North Carolina 28204 —
Novartis Investigative Site Durham North Carolina 27710 —
Novartis Investigative Site Hickory North Carolina 28602 —
Novartis Investigative Site Raleigh North Carolina 27607 —
Novartis Investigative Site Sanford North Carolina 27330 —
Novartis Investigative Site Wilmington North Carolina 28401 —
Novartis Investigative Site Bismarck North Dakota 58501 —
Novartis Investigative Site Bellevue Ohio 44811 —
Novartis Investigative Site Centerville Ohio 45459 —
Novartis Investigative Site Cincinnati Ohio 45219 —
Novartis Investigative Site Columbus Ohio 43210 —
Novartis Investigative Site Columbus Ohio 43221 —
Novartis Investigative Site Dayton Ohio 45408 —
Novartis Investigative Site Toledo Ohio 43614 —
Novartis Investigative Site Toledo Ohio 43623 —
Novartis Investigative Site Oklahoma City Oklahoma 73102 —
Novartis Investigative Site Oklahoma City Oklahoma 73104 —
Novartis Investigative Site Portland Oregon 97225 —
Novartis Investigative Site Springfield Oregon 97477 —
Novartis Investigative Site Greensburg Pennsylvania 15601 —
Novartis Investigative Site Meadowbrook Pennsylvania 19046 —
Novartis Investigative Site Philadelphia Pennsylvania 19107-5098 —
Novartis Investigative Site Philadelphia Pennsylvania 19107 —
Novartis Investigative Site Pittsburgh Pennsylvania 15243 —
Novartis Investigative Site Willow Grove Pennsylvania 19090 —
Novartis Investigative Site Beaufort South Carolina 29902 —
Novartis Investigative Site Camden South Carolina 29020 —
Novartis Investigative Site Charleston South Carolina 29406 —
Novartis Investigative Site Greer South Carolina 29650 —
Novartis Investigative Site Mt. Pleasant South Carolina 29464 —
Novartis Investigative Site Old Point Station South Carolina 29707 —
Novartis Investigative Site Spartanburg South Carolina 29303 —
Novartis Investigative Site Spartanburg South Carolina 29307 —
Novartis Investigative Site Knoxville Tennessee 37922 —
Novartis Investigative Site Nashville Tennessee 37205 —
Novartis Investigative Site Nashville Tennessee 37212 —
Novartis Investigative Site Brownwood Texas 76801 —
Novartis Investigative Site Dallas Texas 75214 —
Novartis Investigative Site Dallas Texas 75390 —
Novartis Investigative Site Houston Texas 77005 —
Novartis Investigative Site Houston Texas 77025 —
Novartis Investigative Site Kingwood Texas 77339 —
Novartis Investigative Site Mansfield Texas 76063 —
Novartis Investigative Site San Antonio Texas 78229 —
Novartis Investigative Site Stafford Texas 77477 —
Novartis Investigative Site Sugar Land Texas 77479 —
Novartis Investigative Site Provo Utah 84604 —
Novartis Investigative Site Salt Lake City Utah 84103 —
Novartis Investigative Site Salt Lake City Utah 84132 —
Novartis Investigative Site Alexandria Virginia 22310 —
Novartis Investigative Site Arlington Virginia 22205 —
Novartis Investigative Site Charlottesville Virginia 22911 —
Novartis Investigative Site McLean Virginia 22101 —
Novartis Investigative Site Newport News Virginia 23601 —
Novartis Investigative Site Norfolk Virginia 23507 —
Novartis Investigative Site Richmond Virginia 23228 —
Novartis Investigative Site Richmond Virginia 23924 —
Novartis Investigative Site Vienna Virginia 22182 —
Novartis Investigative Site Winchester Virginia 22601 —
Novartis Investigative Site Richland Washington 99352 —
Novartis Investigative Site Spokane Washington 99208 —
Novartis Investigative Site Tacoma Washington 98405 —
Novartis Investigative Site Wenatchee Washington 98801 —
Novartis Investigative Site Beckley West Virginia 25801 —
Novartis Investigative Site Huntington West Virginia 25701 —
Novartis Investigative Site Green Bay Wisconsin 54311 —
Novartis Investigative Site Milwaukee Wisconsin 53211 —
Novartis Investigative Site Monroe Wisconsin 53566 —
Novartis Investigative Site Neenah Wisconsin 54956 —
Novartis Investigative Site Wisconsin Rapids Wisconsin 54495 —
Novartis Investigative Site Casper Wyoming 82601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01442194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 14, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01442194 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →